Upgrade to SI Premium - Free Trial

Volitionrx Limited (VNRX)

0.31 -0.03 (8.82%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/12/26)

Latest Headlines

Form EFFECT VOLITIONRX LTD September 11, 2026 6:03 AM - SEC Filing Volition Presents Early Stage I Solid Cancer Detection at the ESMO MAP Conference September 10, 2026 8:17 AM - PR NewsWire Form S-3/A VOLITIONRX LTD September 9, 2026 6:04 AM - SEC Filing Form S-3/A VOLITIONRX LTD September 8, 2026 5:09 PM - SEC Filing Form SCHEDULE 13D VOLITIONRX LTD Filed by: Lagoda Investment Management, L.P. September 4, 2026 5:30 PM - SEC Filing Form 8-K VOLITIONRX LTD For: Sep 02 September 2, 2026 4:46 PM - SEC Filing Form 8-K VOLITIONRX LTD For: Aug 27 September 2, 2026 6:05 AM - SEC Filing Volitionrx Limited (VNRX) files for 10M share offering by selling stockholders August 28, 2026 4:23 PM - StreetInsider Form S-3 VOLITIONRX LTD August 28, 2026 4:21 PM - SEC Filing VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets August 26, 2026 9:17 AM - PR NewsWire Volition's sepsis biomarker published in Critical Care Medicine August 26, 2026 8:18 AM - StreetInsider Volition Announces Landmark Clinical Validation of Nu.Q® NETs Biomarker in Sepsis August 26, 2026 8:17 AM - PR NewsWire Form 8-K VOLITIONRX LTD For: Aug 19 August 24, 2026 5:01 PM - SEC Filing Form S-8 VOLITIONRX LTD August 21, 2026 5:05 PM - SEC Filing Benchmark Reiterates Hold Rating on VolitionRX (VNRX) August 17, 2026 9:45 AM - StreetInsider Form SCHEDULE 13G/A VOLITIONRX LTD Filed by: Lagoda Investment Management, L.P. August 14, 2026 4:23 PM - SEC Filing Form 10-Q VOLITIONRX LTD For: Jun 30 August 13, 2026 4:41 PM - SEC Filing Form 8-K VOLITIONRX LTD For: Aug 13 August 13, 2026 4:34 PM - SEC Filing VolitionRx Limited Announces Second Quarter 2026 Financial Results and Business Update August 13, 2026 4:10 PM - PR NewsWire Volition's finger-prick sepsis test shows high lab correlation August 12, 2026 8:17 AM - StreetInsider Volition Demonstrates Utility of Rapid, Point-of-Care Finger-Prick Test in Sepsis Patients August 12, 2026 8:17 AM - PR NewsWire VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update August 11, 2026 4:10 PM - PR NewsWire Form 8-K VOLITIONRX LTD For: Aug 06 August 7, 2026 5:00 PM - SEC Filing Volition Reports Publication of First Peer Reviewed Paper on New Capture-Seq™ Liquid Biopsy Technology August 5, 2026 8:17 AM - PR NewsWire Volition in talks with diagnostic firms over sepsis biomarker test July 30, 2026 8:17 AM - StreetInsider Volition Advances Nu.Q® NETs Platform Towards Commercialization July 30, 2026 8:17 AM - PR NewsWire Form 8-K VOLITIONRX LTD For: Jul 17 July 21, 2026 4:16 PM - SEC Filing Form EFFECT VOLITIONRX LTD July 20, 2026 6:03 AM - SEC Filing Form S-3 VOLITIONRX LTD July 10, 2026 5:28 PM - SEC Filing VolitionRx releases lung cancer study data for Nu.Q test July 7, 2026 8:17 AM - StreetInsider VolitionRx Announces Data Showing the Prognostic Value of its Nu.Q® Cancer Test July 7, 2026 8:17 AM - PR NewsWire Form 8-K VOLITIONRX LTD For: Jun 17 June 18, 2026 5:01 PM - SEC Filing Maxim Group Resumes VolitionRX (VNRX) at Buy June 18, 2026 7:55 AM - StreetInsider VolitionRx and Sysmex partner to optimize NETs diagnostic assay June 17, 2026 8:16 AM - StreetInsider VolitionRx Announces Collaboration with Sysmex June 17, 2026 8:15 AM - PR NewsWire Full Article List